Knockdown of KRT17 by siRNA induces antitumoral effects on gastric cancer cells.
Mihaela Chivu-EconomescuDenisa L DraguLaura G NeculaLilia MateiAna Maria EnciuCoralia BleotuCarmen C DiaconuPublished in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2017)
Our results highlight KRT17 as a possible biomarker in gastric cancer promoting tumor growth, motility, and invasion, and suggest that KRT17 can be a valuable molecular target for development of anti-gastric cancer-specific therapies.